Article Details
Retrieved on: 2024-02-20 17:25:56
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Matinas BioPharma Holdings, Inc. ORALTO Phase 3 trial focused on desired initial target indication of early oral step-down treatment of invasive ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here